← Leaderboards
David Wesley Dowdy
Johns Hopkins University
$17,286,098
Attributed
$25,840,827
Total exposure
14
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.2M · FY2012–25$5M$3.8M$2.5M$1.3M$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$25,840,827 · 14
By mechanism
R01$19,471,891 · 7
R33$3,789,374 · 1
R21$1,240,282 · 3
R61$963,941 · 1
P30$375,339 · 2
Top collaborators
- Adithya Cattamanchi8 shared
- Patrick Pj Phillips5 shared
- Lee Frederick Schroeder5 shared
- Christina Yoon5 shared
- Emily A Kendall4 shared
- Fred C Semitala3 shared
- William N Checkley2 shared
- Ronald Moses Galiwango2 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- Yvonne Commodore-Mensah$3,406,626
- Robert A. Wise$33,179,807
- Philippa Musoke$9,335,883
- Colleen Hanrahan$804,197
- Gregory M Lucas$25,457,285
Others in their field
Top investigators on “Tuberculosis”
- Judith S. Currier · University Of California Los Angeles$301,722,065
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$297,204,160
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$267,912,117
- Lawrence Corey · Fred Hutchinson Cancer Center$255,939,398
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$200,192,298
- Sharon A Nachman · Johns Hopkins University$194,852,226
Research focus
TuberculosisCost EffectivenessInnovationIncidencePrimary OutcomeDiagnosisTransmission ProcessCostResourcesEffectivenessAfrica South Of The SaharaBaseCountryRandomizedEpidemiologyEpidemicMortalityPublic HealthUgandaCharacteristicsClinicScale UpPrevalenceInfrastructure
Grant awards (49)
Hotspot versus clinic-based active case finding for TB in Uganda: A pragmatic randomized trial$576,980
R01 · FY2025 · HL
Causality of Post-TB Lung Disease: Population-Level Evidence from Rural Uganda$475,130
R01 · FY2025 · AI · contact PI
Options for Delivery of Short-Course Tuberculosis Preventive Therapy: The 3HP Options Trial$427,901
R01 · FY2025 · HL
Causality of Post-TB Lung Disease: Population-Level Evidence from Rural Uganda$422,318
R01 · FY2025 · AI · contact PI
Options for Delivery of Short-Course Tuberculosis Preventive Therapy: The 3HP Options Trial$144,978
R01 · FY2025 · HL
Bioinformatics/Modeling/Biostatistics Core$125,568
P30 · FY2025 · AI · contact PI
Options for Delivery of Short-Course Tuberculosis Preventive Therapy: The 3HP Options Trial$69,299
R01 · FY2025 · HL
Point-of-care C-reactive protein-based tuberculosis screening in people living with HIV: a randomized trial$711,595
R33 · FY2024 · HL
Hotspot versus clinic-based active case finding for TB in Uganda: A pragmatic randomized trial$560,353
R01 · FY2024 · HL
Bioinformatics/Modeling/Biostatistics Core$125,976
P30 · FY2024 · AI · contact PI
Point-of-care C-reactive protein-based tuberculosis screening in people living with HIV: a randomized trial$1,056,953
R33 · FY2023 · HL
Understanding and Improving the Effectiveness of Public Health Laboratory Networks for Infectious Diseases in Ghana$631,451
R01 · FY2023 · AI
Innovative contact tracing strategies for detecting TB in mobile rural and urban South African populations$617,787
R01 · FY2023 · AI · contact PI
Hotspot versus clinic-based active case finding for TB in Uganda: A pragmatic randomized trial$544,637
R01 · FY2023 · HL
Bioinformatics/Modeling/Biostatistics Core$123,795
P30 · FY2023 · AI · contact PI
Point-of-care C-reactive protein-based tuberculosis screening in people living with HIV: a randomized trial$1,060,388
R33 · FY2022 · HL
Understanding and Improving the Effectiveness of Public Health Laboratory Networks for Infectious Diseases in Ghana$666,314
R01 · FY2022 · AI
Options for Delivery of Short-Course Tuberculosis Preventive Therapy: The 3HP Options Trial$594,179
R01 · FY2022 · HL
Innovative contact tracing strategies for detecting TB in mobile rural and urban South African populations$586,119
R01 · FY2022 · AI · contact PI
Hotspot versus clinic-based active case finding for TB in Uganda: A pragmatic randomized trial$544,014
R01 · FY2022 · HL
PredicTB: Validating a clinical risk score for early management of tuberculosis in Ugandan primary health clinics$162,809
R21 · FY2022 · AI · contact PI
Point-of-care C-reactive protein-based tuberculosis screening in people living with HIV: a randomized trial$960,438
R33 · FY2021 · HL
Understanding and Improving the Effectiveness of Public Health Laboratory Networks for Infectious Diseases in Ghana$677,548
R01 · FY2021 · AI
Options for Delivery of Short-Course Tuberculosis Preventive Therapy: The 3HP Options Trial$597,392
R01 · FY2021 · HL
Innovative contact tracing strategies for detecting TB in mobile rural and urban South African populations$561,785
R01 · FY2021 · AI · contact PI
PredicTB: Validating a clinical risk score for early management of tuberculosis in Ugandan primary health clinics$215,974
R21 · FY2021 · AI · contact PI
Understanding and Improving the Effectiveness of Public Health Laboratory Networks for Infectious Diseases in Ghana$679,698
R01 · FY2020 · AI
A Comprehensive Snapshot of Tuberculosis Transmission in an Urban Ugandan Community$678,785
R01 · FY2020 · HL · contact PI
Options for Delivery of Short-Course Tuberculosis Preventive Therapy: The 3HP Options Trial$607,486
R01 · FY2020 · HL
Innovative contact tracing strategies for detecting TB in mobile rural and urban South African populations$587,975
R01 · FY2020 · AI · contact PI
Innovative Contact Tracing Strategies for Detecting TB in Mobile Rural and Urban South African Populations$143,847
R01 · FY2020 · AI · contact PI
Point-of-care C-reactive protein-based tuberculosis screening in people living with HIV: a randomized trial$963,941
R61 · FY2019 · HL
Understanding and Improving the Effectiveness of Public Health Laboratory Networks for Infectious Diseases in Ghana$698,829
R01 · FY2019 · AI
A Comprehensive Snapshot of Tuberculosis Transmission in an Urban Ugandan Community$667,381
R01 · FY2019 · HL · contact PI
Innovative contact tracing strategies for detecting TB in mobile rural and urban South African populations$653,812
R01 · FY2019 · AI · contact PI
Comparative Effectiveness/Implementation of TB Case Finding in Rural South Africa$624,971
R01 · FY2019 · AI · contact PI
Options for Delivery of Short-Course Tuberculosis Preventive Therapy: The 3HP Options Trial$614,073
R01 · FY2019 · HL
Options for Delivery of Short-Course Tuberculosis Preventive Therapy: The 3HP Options Trial$725,916
R01 · FY2018 · HL
A Comprehensive Snapshot of Tuberculosis Transmission in an Urban Ugandan Community$625,638
R01 · FY2018 · HL · contact PI
Comparative Effectiveness/Implementation of TB Case Finding in Rural South Africa$594,641
R01 · FY2018 · AI · contact PI
Assessing Social Justice in Economic Evaluation to Scale up Novel MDR-TB Regimens$408,601
R01 · FY2018 · AI · contact PI
A Comprehensive Snapshot of Tuberculosis Transmission in an Urban Ugandan Community$620,974
R01 · FY2017 · HL · contact PI
Comparative Effectiveness/Implementation of TB Case Finding in Rural South Africa$600,728
R01 · FY2017 · AI · contact PI
Comparative Effectiveness/Implementation of TB Case Finding in Rural South Africa$599,898
R01 · FY2016 · AI · contact PI
Comparative Effectiveness/Implementation of TB Case Finding in Rural South Africa$640,453
R01 · FY2015 · AI · contact PI
Comparative Effectiveness of Rapid TB Diagnostics in Uganda$197,402
R21 · FY2014 · AI · contact PI
Comparative Effectiveness of Rapid TB Diagnostics in Uganda$230,747
R21 · FY2013 · AI · contact PI
A User-Friendly Epidemic-Economic Model of Diagnostic Tests for Tuberculosis$190,350
R21 · FY2013 · AI · contact PI
A User-Friendly Epidemic-Economic Model of Diagnostic Tests for Tuberculosis$243,000
R21 · FY2012 · AI · contact PI